Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vignan Yogendrakumar

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Stroke|September 10, 2025
Efficacy of Tenecteplase in Large Vessel Occlusion Stroke Within 24 Hours of Symptom Onset: The ETERNAL-LVO Randomized Controlled TrialVignan Yogendrakumar, Bruce C V Campbell, Leonid Churilov, et al.
Neurology|April 28, 2025
Effect of Thrombolytics on Delayed Reperfusion After Incomplete Thrombectomy: Target Trial EmulationAdnan Mujanovic, Vignan Yogendrakumar, Felix C Ng, et al.
Circulation|March 18, 2026
Prognostic Factors for Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke: A Systematic Review and Meta-AnalysisFaizan Khan, Vignan Yogendrakumar, Ronda Lun, et al.
Stroke|March 30, 2026
Cerebral Edema in Patients With Large Ischemic Core After Thrombectomy: A Secondary Analysis of SELECT2 Randomized TrialFelix Ng, Vignan Yogendrakumar, Hannah Johns, et al.
NEJM Evidence|December 22, 2025
A Randomized Trial of Telemedicine Models of Care on a Mobile Stroke UnitVignan Yogendrakumar, Anna H Balabanski, Hannah Johns, et al.
The Lancet. Neurology|May 7, 2022
Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trialAndrew Bivard, Henry Zhao, Leonid Churilov, et al.
Stroke|March 28, 2025
Association of Ischemic Core Hypodensity With Thrombectomy Treatment Effect in Large Core Stroke: A Secondary Analysis of the SELECT2 Randomized Controlled TrialVignan Yogendrakumar, Bruce C V Campbell, Hannah Johns, et al.
Stroke and Vascular Neurology|December 1, 2021
Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trialNawaf Yassi, Henry Zhao, Leonid Churilov, et al.
The Lancet. Neurology|April 22, 2024
Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trialNawaf Yassi, Henry Zhao, Leonid Churilov, et al.
The Lancet. Neurology|June 16, 2024
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trialMark W Parsons, Vignan Yogendrakumar, Leonid Churilov, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Stroke|September 10, 2025
Efficacy of Tenecteplase in Large Vessel Occlusion Stroke Within 24 Hours of Symptom Onset: The ETERNAL-LVO Randomized Controlled TrialVignan Yogendrakumar, Bruce C V Campbell, Leonid Churilov, et al.
Neurology|April 28, 2025
Effect of Thrombolytics on Delayed Reperfusion After Incomplete Thrombectomy: Target Trial EmulationAdnan Mujanovic, Vignan Yogendrakumar, Felix C Ng, et al.
Circulation|March 18, 2026
Prognostic Factors for Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke: A Systematic Review and Meta-AnalysisFaizan Khan, Vignan Yogendrakumar, Ronda Lun, et al.
Stroke|March 30, 2026
Cerebral Edema in Patients With Large Ischemic Core After Thrombectomy: A Secondary Analysis of SELECT2 Randomized TrialFelix Ng, Vignan Yogendrakumar, Hannah Johns, et al.
NEJM Evidence|December 22, 2025
A Randomized Trial of Telemedicine Models of Care on a Mobile Stroke UnitVignan Yogendrakumar, Anna H Balabanski, Hannah Johns, et al.
The Lancet. Neurology|May 7, 2022
Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trialAndrew Bivard, Henry Zhao, Leonid Churilov, et al.
Stroke|March 28, 2025
Association of Ischemic Core Hypodensity With Thrombectomy Treatment Effect in Large Core Stroke: A Secondary Analysis of the SELECT2 Randomized Controlled TrialVignan Yogendrakumar, Bruce C V Campbell, Hannah Johns, et al.
Stroke and Vascular Neurology|December 1, 2021
Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trialNawaf Yassi, Henry Zhao, Leonid Churilov, et al.
The Lancet. Neurology|April 22, 2024
Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trialNawaf Yassi, Henry Zhao, Leonid Churilov, et al.
The Lancet. Neurology|June 16, 2024
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trialMark W Parsons, Vignan Yogendrakumar, Leonid Churilov, et al.
Pageof 9